Department of Growth and Reproduction, Rigshospitalet
Copenhagen, Capital Region, 2100, Denmark
Location status: Recruiting
NCT Number: NCT06573177
This observational study focuses on evaluating the effect of the current health care program for Danish children and adolescents with gender incongruence, which was established in January 2016. Somatic outcome parameters include growth, bone health, body composition, metabolic parameters, hormone levels and concurrent diseases. Psychosocial parameters include the trajectory of gender incongruence development, mental health, i.e. autism spectrum disorders, behavioural problems, self-harm, suicidal ideation and psychiatric diagnoses, and social context, i.e. family demographics, education, minority stress.
This study aims to:
1. Characterise the psychosocial profile of all children and adolescents referred for treatment, as well as the history of gender identity development and treatment trajectories. 2. Systematically evaluate biological parameters before and during hormonal treatment with gonadotropin-releasing hormone (GnRH) analogues and cross-sex hormones, and to establish a biobank for those in hormone treatment.
The investigators hypothesise that intervention with counselling and hormonal treatment is safe and has a positive impact on psychosocial well-being of transgender youngsters. The overall aim is to provide data for improving future family counselling, clinical care, patient satisfaction, patient safety and ultimately quality-of-life.
Interested in participating?
Request InfoUp to 18 year
All sexes
Observational
Copenhagen, Capital Region, 2100, Denmark
Location status: Recruiting
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Referral to the national gender identity service consisting of the Sexological Clinic, Child and Adolescent Mental Health Center, and Department of Growth and Reproduction in the Capital Region of Denmark.
Time frame: 8 years
BMI will be calculated from height and weight (kg/m^2) measurements
Time frame: 8 years
Tanner stages of puberty (1-5) are obtained by clinical examination
Time frame: 8 years
Whole body dual-energy x-ray absorptiometry (DXA) will determine BMD Z-score for age and sex
Time frame: 8 years
Whole body dual-energy x-ray absorptiometry (DXA) will measure body fat percentage (%)
Time frame: 8 years
Whole body dual-energy x-ray absorptiometry (DXA) will measure lean mass (kg)
Time frame: 8 years
Changes in reproductive hormone levels (%)
Time frame: 8 years
Changes in adrenal hormone levels (%)
Time frame: 8 years
Changes in blood pressure measurement (mm Hg)
Time frame: 8 years
Changes of endometrium (thickness in mm) during testosterone treatment
Time frame: 8 years
Change in number of follicles (n) during testosterone treatment
Time frame: 8 years
Sperm Count (at cryopreservation)
Time frame: 8 years
Sperm motility (at cryopreservation)
Time frame: 8 years
Number of participants with registered ICD10 diagnoses
Time frame: 8 years
eg. socioeconomic status
Time frame: 8 years
Based on screening for psychopathology using validated tests, as indicated:
Schedule for Affective Disorders and Schizophrenia for School-age children (K-SADS):
A diagnostic tool used to assess psychiatric disorders in children and adolescents. It is a semi-structured interview guide used to identify psychiatric conditions.
Wechsler Intelligence Scale for Children (WISC 4/5) or Wechsler Adult Intelligence Scale (WAIS 4): General cognitive function is measured on a scale from 40-160 which is used as an intelligence quotient. A higher score: A higher cognitive function.
Rorschach: A projective psychological test. The test uses a series of ink blots to evaluate a person's mental functions and emotional state by analysing their perceptions of the figures. The test is based on complex and subjective scoring and interpretation.
Time frame: 8 years
Screening using validated tests:
Behavior Rating Inventory of Executive Function (BRIEF): General executive function is measured on a normative scale with T-scores from 20-80. A higher score: more executive difficulties.
Attention Deficit/Hyperactive Disorder-Rating Scale (ADHD-RS): Attention Deficit Hyperactive Disorder traits measured on a normative scale with T-scores from 0-78. A higher score: More Attention Deficit Hyperactive Disorder traits
Time frame: 8 years
Screening using validated tests:
Social Responsiveness Scale (SRS): Autism spectrum disorder (ASD) traits measured on a scale with T-scores from 0-76+. A higher score: More autistic traits.
Autism Diagnostic Observation Schedule (ADOS): A structured observational tool to assess ASD. A trait is rated on a scale from 0 to 3. 0 indicates absence of a behaviour and 3 indicates severe occurrence of a behaviour. The total score determines the presence and severity of ASD. The cut-off scores are 10 for autism and 7 for ASD traits.
Autism Diagnostic Interview-Revised (ADI-R): A structured interview used to assess ASD traits. Interview questions are scored on a scale from 0-3. 0 indicates absence of a behaviour and 3 indicates severe occurrence of a behaviour. The scores compared with cut-off values determine the presence of ASD. Cut-off values for each trait: Social interaction: cut-off 10; Communication skills: cut-off 8; Restrictive and repetitive behaviour patterns: cut-off 3.
Time frame: 8 years
Children's Global Assessment Scale (C-GAS, range 1-100)
Time frame: 8 years
Global Assessment of Psychosocial Disability (GAPD, range 0-8)
Time frame: 8 years
Number of participants with self-reported suicide thoughts or attempts (interview)
Time frame: 8 years
Number participants with self-reported abuse of alcohol, drugs or medications (interview)
Time frame: 8 years
Age at onset of GI and social transitioning (interview)
Time frame: 8 years
Interviews with youngsters and their families to explore:
Time frame: 8 years.
Serum, plasma, DNA at -20 and -80 degrees Celsius.
Contact information is provided by the study sponsor or research team.
Annamaria GE Giraldi
CONTACT
Katharina M Main
CONTACT
Rigshospitalet, Denmark
Other
Gender Incongruence in Danish Youth (GenDa): An Observational Cohort Study of Danish Children and Adolescents Referred to a National Gender Identity Service
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06774053
Gender Dysphoria, Gender Incongruence
Basel, Switzerland
View Trial DetailsNCT07187947
Cardiovascular (CV) Risk, Cardiovascular Disease (CVD)
Bologna, BO, Italy
View Trial DetailsNCT06953908
Gender Dysphoria, Gender Dysphoria, Adult
Copenhagen, Denmark
View Trial DetailsNCT05318755
Gender Dysphoria, Gender Incongruence
Beijing, Beijing Municipality, China
View Trial Details